Discontinued — last reported Q2 '21
Operating
Loss on Sale of Subsidiary
UnitedHealth Group Loss on Sale of Subsidiary increased by 42.9% to -$72.00M in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 380.0%, from -$15.00M to -$72.00M. This increase may warrant attention — for this metric, lower values are generally preferred.
Analysis
StatementCash Flow Statement
SectionOperating
CategoryCapital Allocation
SignalLower is better
VolatilityVolatile
First reportedQ3 2013
Last reportedQ2 2021
How to read this metric
A loss suggests the asset was sold for less than its book value, potentially indicating poor past investment performance.
Detailed definition
This metric captures the non-cash accounting loss recognized when a subsidiary or business unit is divested. It represen...
Peer comparison
Rare for stable firms; common during periods of portfolio optimization or divestiture programs.
Metric ID:
unh_loss_on_sale_of_subsidiaryHistorical Data
17 periods
| Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | -$7.09B | -$1.23B | -$20.00M | $0.00 | -$15.00M | -$41.00M | -$83.00M | -$126.00M | -$72.00M |
| QoQ Change | — | — | — | — | — | — | — | — | — | +82.7% | +98.4% | +100.0% | — | -173.3% | -102.4% | -51.8% | +42.9% |
| YoY Change | — | — | — | — | — | — | — | — | — | — | — | — | +99.8% | +96.7% | -315.0% | — | -380.0% |
Range-$7.09B – $0.00
Avg YoY Growth-124.6%
Median YoY Growth-109.2%
Business Segments
| Segment | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 |
|---|---|---|---|---|---|---|---|---|
| UnitedHealthcare | -$1.23B | -$20.00M | $0.00 | -$15.00M | -$41.00M | -$83.00M | -$126.00M | -$72.00M |
| Optum Health | $0.00 | $0.00 | $0.00 | $0.00 | — | — | — | — |
| Optum Insight | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Optum Rx | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Total | -$1.23B | -$20.00M | $0.00 | -$15.00M | -$41.00M | -$83.00M | -$126.00M | -$72.00M |
Loss on Sale of Subsidiary at Other Companies
Frequently Asked Questions
- What is UnitedHealth Group's loss on sale of subsidiary?
- UnitedHealth Group (UNH) reported loss on sale of subsidiary of -$72.00M in Q1 2026.
- How has UnitedHealth Group's loss on sale of subsidiary changed year-over-year?
- UnitedHealth Group's loss on sale of subsidiary decreased by 380.0% year-over-year, from -$15.00M to -$72.00M.
- What does loss on sale of subsidiary mean?
- The non-cash accounting loss recorded when selling off a business unit or subsidiary.